دورية أكاديمية
A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer
| العنوان: | A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer |
|---|---|
| المؤلفون: | Chelariu-Raicu, Anca, Nick, Alpa, Urban, Renata, Gordinier, Mary, Leuschner, Carola, Bavisotto, Linda, Molin, Graziela Zibetti Dal, Whisnant, John K., Coleman, Robert L. |
| المساهمون: | University of Texas MD Anderson Cancer Center |
| المصدر: | Gynecologic Oncology ; volume 160, issue 2, page 418-426 ; ISSN 0090-8258 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2021 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Obstetrics and Gynecology, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ygyno.2020.11.013 |
| الإتاحة: | https://doi.org/10.1016/j.ygyno.2020.11.013Test https://api.elsevier.com/content/article/PII:S009082582034124X?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S009082582034124X?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.E5640E9 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ygyno.2020.11.013 |
|---|